Research Papers:
TBX2 over-expression promotes nasopharyngeal cancer cell proliferation and invasion
PDF | HTML | Supplementary Files | How to cite
Metrics: PDF 2410 views | HTML 2912 views | ?
Abstract
Yan Lv1,*, Meng Si2,*, Nannan Chen3,*, Ya Li3,*, Xingkai Ma4, Huijun Yang4, Ling Zhang1, Hongyan Zhu1, Guang-yin Xu1,3, Ge-ping Wu1,4 and C. Cao3
1Center of Translational Medicine, The First People Hospital of Zhangjiagang City, Soochow University, Suzhou, China
2Department of Neurology, The Second Affiliated Hospital of Soochow University, Suzhou, China
3Institute of Neuroscience, Soochow University, Suzhou, China
4Department of Otolaryngology, The First People Hospital of Zhangjiagang City, Soochow University, Suzhou, China
*These authors have contributed equally to this work
Correspondence to:
Ge-ping Wu, email: [email protected]
C. Cao, email: [email protected]
Guang-yin Xu, email: [email protected]
Keywords: TBX2, nasopharyngeal cancer, invasion, proliferation, siRNA
Received: December 06, 2016 Accepted: March 12, 2017 Published: April 13, 2017
ABSTRACT
TBX2 is a member of the T box transcription factor family. Its expression and potential biological functions in nasopharyngeal cancer (NPC) cells are studied here. We showed that TBX2 mRNA and protein expression was significantly elevated in multiple human NPC tissues, as compared with that in adjacent normal tissues. Knockdown of TBX2 by targeted-siRNA significantly inhibited proliferation and invasion of NPC cells (CNE-1 and HONE-1 lines). Meanwhile, TBX2 knockdown also induced G1-phase cell cycle arrest. At the molecular level, we discovered that expressions of several tumor suppressor genes, including p21, p27, phosphatase with tensin homology (PTEN) and E-Cadherin, were increased dramatically after TBX2 knockdown in above NPC cells. Collectively, our results imply that TBX2 over-expression promotes NPC cell proliferation and invasion, possibly via silencing several key tumor suppressor genes.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 17084